Leptin-melanocortin pathway plays an essential role in the body weight regulation. Enhanced melanocortin signaling in the hypothalamus results in both decreased food intake and increased energy expenditure. The discovery of monogenic obesities with dysfunction of melanocortin-4 receptor (MC4R) greatly contributed to understanding of energy balance regulation. This review presents phenotypical characterization and prevalence of the MC4R gene mutations. Genome-wide association studies revealed that MC4R gene is significantly related not only to monogenic obesities but also to common obesity. An interaction of variants in the MC4R gene with fat mass and obesity associated (FTO) gene significantly increases the risk for obesity, particularly in adolescence. On the other hand, about 15 % of the MC4R gene variants result in a gain of function that protects against obesity and is associated with favorable metabolic profile. Long-term attempts to activate the MC4R have recently been finalized by a discovery of setmelanotide, a novel specific MC4R agonist that is devoid of untoward cardiovascular side-effects. The employment of specific MC4R agonists may open new horizons not only in the treatment of rare monogenic obesities but also in some common obesities where stimulation of MC4R could be achieved.

Obesity Management Center Institute of Endocrinology Prague Czech Republic

See more in PubMed

ADAMSKA-PATRUNO E, GOSICK J, CZAJOWSKI P, MALISZEWSKA K, CIBOROWSKI M, GOLONKO A, WAVRUSIEWICZ-KURYLONEK N, CITKO A, WASZCZENIUK M, KRETOWSKI A, GORSKA M. The MC4R genetic variants are associated with lower visceral fat accumulation and higher postprandial relative increase in carbohydrate utilization in humans. Eur J Nutr. 2019;58:2929–2941. doi: 10.1007/s00394-019-01955-0. PubMed DOI PMC

ALDHOON HAINEROVÁ I, ZAMRAZILOVÁ H, SEDLÁČKOVÁ D, HAINER V. Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks. Obes Facts. 2011;4:324–328. doi: 10.1159/000330763. PubMed DOI PMC

ANDERSON EJ, CAKIR I, CARRINGTON SJ, CONE RD, GHAMARI-LANGROUDI M, GILLYARD T, GIMENEZ LE, LITT MJ. 60 years of POMC: regulation of feeding and energy homeostasis by α-MSH. J Mol Endocrinol. 2016;56:T157–T174. doi: 10.1530/JME-16-0014. PubMed DOI PMC

ASLAN IR, RANDIVE SA, ERSOY BA, ROGERS SJ, LUSTIG RH, VAISSE C. Bariatric surgery in a patient with complete MC4R deficiency. Int J Obes (Lond) 2011;35:457–461. doi: 10.1038/ijo.2010.168. PubMed DOI PMC

AYERS KL, GLICKSBERG BS, GARFIELD AS, LONGERICH S, WHITE JA, YANG P, DU L, CHITTENDEN TW, GULCHER JR, ROY S, FIEDOREK F, GOTTESDIENER K, COHEN S, NORTH KE, SCHADT EE, LI SD, CHEN R, Van der PLOEG LHT. Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment. J Clin Endocrinol Metab. 2018;103:2601–2612. doi: 10.1210/jc.2018-00258. PubMed DOI PMC

BENJAMINS JA, NEDELKOSKA L, LISAK RP. Melanocortin receptor subtypes are expressed on cells in the oligodendroglial lineage and signal ACTH protection. J Neurosci Res. 2018;96:427–435. doi: 10.1002/jnr.24141. PubMed DOI

BRANSON R, POTOCZNA N, KRAL JG, LENTES KU, HOEHE MR, HORBER FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med. 2003;348:1096–1103. doi: 10.1056/NEJMoa021971. PubMed DOI

BRADNOVÁ O, VEJRAŽKOVÁ D, VAŇKOVÁ M, LUKÁŠOVÁ P, VČELÁK J, STANICKÁ S, DVOŘÁKOVÁ K, BENDLOVÁ B. Metabolic and hormonal consequnces of the “Obesity Risk” MC4R variant (rs12970134) in Czech women. Physiol Res. 2015;64(Suppl 2):S187–S195. doi: 10.33549/physiolres.933119. PubMed DOI

CAUCHI S, STUTZMANN F, CAVALCANTI-PROENCA C, DURAND E, POUTA A, HARTIKAINEN AL, MARRE M, VOL S, TAMMELIN T, LAITINEN J, GONZALEZ-IZQUIERDO A, BLAKEMORE AI, ELLIOT P, MEYRE D, BALKAU B, JARVELIN MR, FROGUEL P. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J Mol Med (Berl) 2009;87:537–546. doi: 10.1007/s00109-009-0451-6. PubMed DOI

CHEN KY, MUNIYAPPA R, ABEL BS, MULLINS KP, STAKER P, BRYCHTA RJ, ZHAO X, RING M, PSOTA TL, CONE RD, PANARO BL, GOTTESDIENER KM, Van der PLOEG LH, REITMAN ML, SKARULIS MC. RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. J Clin Endocrinol Metab. 2015;100:1639–1645. doi: 10.1210/jc.2014-4024. PubMed DOI PMC

CLEMMENSEN C, FINAN B, FISCHER K, TOM RZ, LEGUTKO B, SEHRER L, HEINE D, GRASSL N, MEYER CW, HENDERSON B, HOFMANN SM, TSCHOP MH, Van der PLOEG LH, MULLER TD. Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice. EMBO Mol Med. 2015;7:288–298. doi: 10.15252/emmm.201404508. PubMed DOI PMC

CLÉMENT K, BIEBERMANN H, FAROOQI IS, Van der PLOEG L, WOLTERS B, POITOU C, PUDER L, FIEDOREJ F, GOTTESDIENER K, KLEINAU G, HEYDER N, SCHEERER P, BLUME-PEYTAVI U, JAHNKE I, SHARMA S, MOKROSINSKI J, WIEGAND S, MULLER A, WEIß K, MAI K, SPRANGER J, GRUTERS A, BLANKENSTEIN O, KRUDE H, KUHNEN P. MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency. Nat Med. 2018;24:551–555. doi: 10.1038/s41591-018-0015-9. PubMed DOI

COLLET TH, DUBERN B, MOKROSINSKI J, CONNORS H, KEOGH JM, MENDES De OLIVEIRA E, HENNING E, POITOU-BERNERT C, OPPERT JM, TOUNIAN P, MARCHELLI F, ALILI R, Le BEYEC J, PÉPIN D, LACORTE JM, GOTTESDIENER A, BOUNDS R, SHARMA S, FOLSTER C, HENDERSON B, O’RAHILLY S, STONER E, GOTTESDIENER K, PANARO BL, CONE RD, CLÉMENT K, FAROOQI IS, Van der PLOEG LHT. Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency. Mol Metab. 2017;6:1321–1329. doi: 10.1016/j.molmet.2017.06.015. PubMed DOI PMC

Da SILVA AA, Do CARMO JM, WANG Z, HALL JE. Melanocortin-4 receptors and sympathetic nervous system activation in hypertension. Curr Hypertens Rep. 2019;21:46. doi: 10.1007/s11906-019-0951-x. PubMed DOI PMC

DUBERN B, CLÉMENT K, PELLOUX V, FROGUEL P, GIRARDET JP, GUY-GRAND B, TOUNIAN P. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and α-melanocyte-stimulating hormone genes in severely obese children. J Pediatr. 2001;139:204–209. doi: 10.1067/mpd.2001.116284. PubMed DOI

DUŠÁTKOVÁ L, ZAMRAZILOVÁ H, SEDLÁČKOVÁ B, VČELÁK J, HLAVATÝ P, ALDHOON HAINEROVÁ I, KORENKOVÁ V, BRADNOVÁ O, BENDLOVÁ B, KUNEŠOVÁ M, HAINER V. Association of obesity susceptibility gene variants with metabolic syndrome and related traits in 1,443 Czech adolescents. Folia Biol (Praha) 2013;59:123–133. PubMed

DWIVEDI OP, TABASSUM R, CHAUHAN G, KAUR I, GHOSH S, MARWAHA RK, TANDON N, BHARADWAJ D. Strong influence of variants near MC4R on adiposity in children and adults: a cross-sectional study in Indian population. J Hum Genet. 2013;58:27–32. doi: 10.1038/jhg.2012.129. PubMed DOI

FAN W, BOSTON BA, KESTERSON RA, HRUBY VJ, CONE RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 1997;385:165–168. doi: 10.1038/385165a0. PubMed DOI

FAROOQI IS, KEOGH JM, YEO GS, LANK EJ, CHEETHAM T, O’RAHILLY S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348:1085–1095. doi: 10.1056/NEJMoa022050. PubMed DOI

FERNANDES AE, De MELO ME, FUJIWARA CT, PIOLTINE MB, MATIOLI SR, SANTOS A, CERCATO C, HALPERN A, MANCINI MC. Associations between a common variant near the MC4R gene and serum triglyceride levels in an obese pediatric cohort. Endocrine. 2015;49:653–658. doi: 10.1007/s12020-015-0616-8. PubMed DOI

FRAYLING TM, TIMPSON NJ, WEEDON MN, ZEGGINI E, FREATHY RM, LINDGREN CM, PERRY JR, ELLIOT KS, LANGO H, RAYNER NW, SHIELDS B, ET AL. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–894. doi: 10.1126/science.1141634. PubMed DOI PMC

FRIEDMAN JM. The alphabet of weight control. Nature. 1997;385:119–120. doi: 10.1038/385119a0. PubMed DOI

FRIEDMAN JM, HALAAS JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–770. doi: 10.1038/27376. PubMed DOI

GAVINI CK, JONES WC, 2ND, NOVAK CM. Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis. J Physiol. 2016;594:5285–5301. doi: 10.1113/JP272352. PubMed DOI PMC

GAVINI CK, COOK TM, RADEMACHER DJ, MANSUY-AUBERT V. Hypothalamic C2-domain protein involved in MC4R trafficking and control of energy balance. Metabolism. 2019;102:153990. doi: 10.1016/j.metabol.2019.153990. PubMed DOI

GELLER F, REICHWALD K, DEMPFLE A, ILLIG T, VOLLMERT C, HERPETZ S, SIFFERT W, PLATZER M, HESS C, GUDERMANN T, BIEBERMANN H, WICHMANN HE, SCHAFER H, HINNEY A, HEBEBRAND J. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet. 2004;74:572–581. doi: 10.1086/382490. PubMed DOI PMC

GREENFIELD JR. Melanocortin signalling and the regulation of blood pressure in human obesity. J Neuronedocrinol. 2011;23:186–193. doi: 10.1111/j.1365-2826.2010.02088.x. PubMed DOI

HAINER V, STUNKARD AJ, KUNEŠOVÁ M, PAŘÍZKOVÁ J, ŠTICH V, ALLISON DB. Intrapair resemblance in very low calorie diet-induced weight loss in female obese identical twins. Int J Obes Relat Metab Disord. 2000;24:1051–1057. doi: 10.1038/sj.ijo.0801358. PubMed DOI

HAINER V, ZAMRAZILOVÁ H, SPÁLOVÁ J, HAINEROVÁ I, KUNEŠOVÁ M, ALDHOON B, BENDLOVÁ B. Role of hereditary factors in weight loss and its maintenance. Physiol Res. 2008;57(Suppl 1):S1–S15. PubMed

HAINEROVÁ I, LARSEN LH, HOLST B, FINKOVÁ M, HAINER V, LEBL J, HANSEN T, PEDERSEN O. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis. J Clin Endocrinol Metab. 2007;92:3689–3696. doi: 10.1210/jc.2007-0352. PubMed DOI

HART SAILORS ML, FOLSOM AR, BALLANTYNE CM, HOELSCHER DM, JACKSON AS, LINDA KAO WH, PANKOW JS, BRAY MS. Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study. Diabetes Obes Metab. 2007;9:548–557. doi: 10.1111/j.1463-1326.2006.00637.x. PubMed DOI

HEBEBRAND J, GELLER F, DEMPFLE A, HEINZEL-GUTENBRUNNER M, RAAB M, GERBER G, WERMTER AK, HORRO FF, BLUNDELL J, SCHAFER H, REMSCHMIDT H, HERPETZ S, HINNEY A. Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations. Mol Psychiatry. 2004;9:796–800. doi: 10.1038/sj.mp.4001491. PubMed DOI

HEBEBRAND J, HINNEY A, KNOLL N, VOLCKMAR AL, SCHERAG A. Molecular genetic aspects of weight regulation. Dtsch Arzt Int. 2013;110:338–344. doi: 10.3238/arztebl.2013.0338. PubMed DOI PMC

HEID IM, VOLLMERT C, HINEY A, DORING A, GELLER F, LOWEL H, WICHMAN HE, ILLIG T, HEBEBRAND J, KRONENBERG F, KORA GROUP. Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet. 2005;42:e21. doi: 10.1136/jmg.2004.027011. PubMed DOI PMC

HINNEY A, VOLCKMAR AL, KNOLL N. Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci. 2013;114:147–191. doi: 10.1016/B978-0-12-386933-3.00005-4. PubMed DOI

HOLLAND J, SORRELLl J, YATES E, SMITH K, ARBABI S, ARNOLD M, RIVIR M, MORANO R, CHEN J, ZHANG X, DIMARCHI R, WOODS SC, SANCHEZ-GURMACHES J, WOHLEB E, PEREZ-TILVE D. A brain-melanocortin-vagus axis mediates adipose tissue expansion independently of energy intake. Cell Rep. 2019;27:2399–2410. doi: 10.1016/j.celrep.2019.04.089. PubMed DOI PMC

HUSZAR D, LYNCH CA, FAIRCHILD-HUNTRESS V, DUNMORE JH, FANG Q, BERKEMEIER LR, GU W, KESTERSON RA, BOSTON BA, CONE RD, SMITH FJ, CAMPFIELD LA, BURN P, LEE F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131–141. doi: 10.1016/S0092-8674(00)81865-6. PubMed DOI

HUVENNE H, DUBERN B, CLÉMENT K, POITOU C. Rare genetic forms of obesity: clinical approach and current treatments in 2016. Obes Facts. 2016;9:158–173. doi: 10.1159/000445061. PubMed DOI PMC

KAMERMANS A, VERHOEVEN T, Van HET HOF B, KONING JJ, BORGHUIS L, WITTE M, Van HORSSEN J, De VRIES HE, RIJNSBURGER M. Setmelanotide, a novel, selective melanocortin receptor-4 agonist exerts anti-inflammatory actions in astrocytes and promotes an anti-inflammatory macrophage phenotype. Front Immunol. 2019;10:2312. doi: 10.3389/fimmu.2019.02312. eCollection 2019. PubMed DOI PMC

KASK A, RAGO L, WIKBERG JES, SCHIOTH HB. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol. 1998;360:15–19. doi: 10.1016/S0014-2999(98)00699-2. PubMed DOI

KATSUURA-KAMANO S, UEMURA H, ARISAWA K, YAMAGUCHI M, HAMAJIMA N, WAKAI K, OKADA R, SUZUKI S, TAGUCHI N, KITA Y, OHNAKA K, KAIRUPAN TS, MATSUI D, OZE I, MIKAMI H, KUBO M, TANAKA H. A polymorphism near MC4R gene (rs17782313) is associated with serum triglyceride levels in the general Japanese population: the J-MICC Study. Endocrine. 2014;47:81–89. doi: 10.1007/s12020-014-0306-y. PubMed DOI

KIEVIT P, HALEM H, MARKS DL, DONG JZ, GLAVAS MM, SINNAYAH P, PRANGER L, COWLEY MA, GROVE KL, CULLER MD. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes. 2013;62:490–497. doi: 10.2337/db12-0598. PubMed DOI PMC

KIRWAN P, KAY RG, BROUWERS B, HERRNAZ-PÉREZ V, JURA M, LARRAUFIE P, JERBER J, PEMBROKE J, BARTELS T, WHITE A, GRIBBLE FM, REIMANN F, FAROOQI IS, O’RAHILLY S, MERKLE FT. Quantitative mass spectrometry for human melanocortin peptides in vitro and in vivo suggests prominent roles for β-MSH and desacetyl α-MSH in energy homeostasis. Mol Metab. 2018;17:82–97. doi: 10.1016/j.molmet.2018.08.006. PubMed DOI PMC

KOOCHAKPOOR G, HOSSEINI-ESFAHANI F, DANESHPOUR MS, HOSSEINI SA, MIRMIRAN P. Effect of interactions of polymorphisms in the Melanocortin-4 receptor gene with dietary factors on the risk of obesity and type 2 diabetes: a systematic review. Diabet Med. 2016;33:1026–1034. doi: 10.1111/dme.13052. PubMed DOI

KRING SI, HOLST C, TOUBRO S, ASTRUP A, HANSEN T, PEDERSEN O, SORENSEN TI. Common variants near MC4R in relation to body fat, body fat distribution, metabolic traits and energy expenditure. Int J Obes (Lond) 2010;34:182–189. doi: 10.1038/ijo.2009.215. PubMed DOI

KUHNEN P, CLÉMENT K, WIEGAND S, BLANKENSTEIN O, GOTTESDIENER K, MARTINI LL, MAI K, BLUME-PEYTAVI U, GRUTERS A, KRUDE H. Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist. N Engl J Med. 2016;375:240–246. doi: 10.1056/NEJMoa1512693. PubMed DOI

LAZOPOULOU N, GKIOKA E, NTALLA I, PERVANIDOU P, MAGIAKOU AM, ROMA-GIANNIKOU E, CHROUSOS GP, PAPASSOTIRIOU I, DEDOUSSIS G, KANAKA-GANTENBEIN C. The combined effect of MC4R and FTO risk alleles on childhood obesity in Greece. Hormones. 2015;14:126–133. doi: 10.14310/horm.2002.1524. PubMed DOI

LEE YS, CHALLIS BG, THOMPSON DA, YEO GS, KEOGH JM, MADONNA ME, WRAIGHT V, SIMS M, VATIN V, MEYRE D, SHIELD J, BURREN C, IBRAHIM Z, CHEETHAM T, SWIFT P, BLACKWOOD A, HUNG CC, WAREHAM NJ, FROGUEL P, MILLHAUSER GL, O’RAHILLY S, FAROOQI IS. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3:135–140. doi: 10.1016/j.cmet.2006.01.006. PubMed DOI

LIU G, ZHU H, LAGOU V, GUTIN B, BARBEAU P, TREIBER FA, DONG Y, SNIEDER H. Common variants near melanocortin 4 receptor are associated with general and visceral adiposity in European- and African-American youth. J Pediatr. 2010;156:598–605. doi: 10.1016/j.jpeds.2009.10.037. PubMed DOI PMC

LOOS RJ. The genetic epidemiology of melanocortin 4 receptor variants. Eur J Pharmacol. 2011;660:156–164. doi: 10.1016/j.ejphar.2011.01.033. PubMed DOI

LOOS RJ, LINDGREN CM, LI S, WHEELER E, ZHAO JH, PROKOPENKO I, INOUYE M, FREATHY RM, ATTWOOD AP, BECKMANN JS, BERNDT SI, ET AL. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768–775. doi: 10.1038/ng.140. PubMed DOI PMC

LOTTA LA, MOKROSINSKI J, MENDES De OLIVEIRA E, LI C, SHARP SJ, LUAN J, BROUWERS B, AYINAMPUDI V, BOWKER N, KERRISON N, KAIMAKIS V, HOULT D, STEWART ID, WHEELER E, DAY FR, PERRY JRB, LANGENBERG C, WAREHAM NJ, FAROOQI IS. Human gain-of-function MC4R variants show signaling bias and protect against obesity. Cell. 2019;177:597–607. doi: 10.1016/j.cell.2019.03.044. PubMed DOI PMC

LUBRANO-BERTHELIER C, Le STUNFF C, BOUGNERES P, VAISSE C. A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans. J Clin Endocrinol Metab. 2004;89:2028–2032. doi: 10.1210/jc.2003-031993. PubMed DOI

MERGEN M, MERGEN H, OZATA M, ONER R, ONER C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab. 2001;86:3448–3451. doi: 10.1210/jcem.86.7.7809. PubMed DOI

MOUNTJOY KG, ROBBINS LS, MORTRUD MT, CONE RD. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992;257:1248–1251. doi: 10.1126/science.1325670. PubMed DOI

MULLER TD, TSCHOP MH, O’RAHILLY S. Metabolic precision medicines: curing POMC deficiency. Cell Metab. 2016;24:194–195. doi: 10.1016/j.cmet.2016.07.006. PubMed DOI

NEDVÍDKOVÁ J, SMITKA K, KOPSKÝ V, HAINER V. Adiponectin, an adipocyte-derived protein. Physiol Res. 2005;54:133–140. PubMed

REINEHR T, HEBEBRAND J, FRIEDEL S, TOSCHKE AM, BRUMM H, BIEBERMANN H, HINNEY A. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Obesity (Silver Spring) 2009;17:382–389. doi: 10.1038/oby.2008.422. PubMed DOI

RESENDE CMM, DURSO DF, BORGES KBG, PEREIRA RM, RODRIGUES GKD, RODRIGUES KF, SILVA JLP, RODRIGUES EC, FRANCO GR, ALVAREZ-LEITE JI. The polymorphism rs17782313 near MC4R gene is related with anthropometric changes in women submitted to bariatric surgery over 60 months. Clin Nutr. 2018;37:1286–1292. doi: 10.1016/j.clnu.2017.05.018. PubMed DOI

RUTANEN J, PIHLAJAMAKI J, KARHAPAA P, VAUHKONEN I, KUUSISTO J, MOILANEN MYKKANEN L, LAAKSO M. The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain. Obes Res. 2004;12:1060–1066. doi: 10.1038/oby.2004.133. PubMed DOI

SHARMA S, GARFIELD AS, SHAH B, KLEYN P, ICHETOVKIN I, MOELLER IH, MOWREY WR, Van der PLOEG LHT. Current mechanistic and pharmacodynamic understanding of melanocortin-4 receptor activation. Molecules. 2019;24:E1892. doi: 10.3390/molecules24101892. PubMed DOI PMC

SHEN WJ, YAP T, KONG X, WILLIAMS KW, LIU T. Melanocortin neurons: multiple routes to regulation of metabolism. Biochim Biophys Acta Mol Basis Dis. 2017;1863:2477–2485. doi: 10.1016/j.bbadis.2017.05.007. PubMed DOI PMC

STANIKOVA D, SUROVA M, TICHA L, PETRASOVA M, VIRGOVA D, HUCKOVA M, SKOPKOVA M, LOBOTKOVA D, VALENTINOVA L, MOKAN M, STANIK J, KLIMES I, GASPERIKOVA D. Melanocortin-4 receptor gene mutations in obese Slovak children. Physiol Res. 2015;64:883–890. doi: 10.33549/physiolres.932968. PubMed DOI

TREVASKIS JL, GAWRONSKA-KOZAK B, SUTTON GM, McNEILL M, STEPHENS JM, SMITH SR, BUTLER AA. Role of adiponectin and inflammation in insulin resistance of Mc3r and Mc4r knockout mice. Obesity (Silver Spring) 2007;15:2664–2672. doi: 10.1038/oby.2007.318. PubMed DOI PMC

VALETTE M, POITOU C, Le BEYEC J, BOUILLOT JL, CLEMENT K, CZERNICHOW S. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLoS One. 2012;7:e48221. doi: 10.1371/journal.pone.0048221. PubMed DOI PMC

WANG D, MA J, ZHANG S, HINNEY A, HEBEBRAND J, WANG Y, WANG HJ. Association of the MC4R V103I polymorphism with obesity: a Chinese case-control study and meta-analysis in 55,195 individuals. Obesity (Silver Spring) 2010;18:573–579. doi: 10.1038/oby.2009.268. PubMed DOI

XI B, CHANDAK GR, SHEN Y, WANG Q, ZHOU D. Association between common polymorphism near the MC4R gene and obesity risk: a systematic review and meta-analysis. PLoS One. 2012a;7:e45731. doi: 10.1371/journal.pone.0045731. PubMed DOI PMC

XI B, TAKEUCHI F, CHANDAK GR, KATO N, PAN HW, AGEN-T2D CONSORTIUM, ZHOU DH, PAN HY, MI J. Common polymorphism near the MC4R gene is associated with type 2 diabetes: data from a meta-analysis of 123,373 individuals. Diabetologia. 2012b;55:2660–2666. doi: 10.1007/s00125-012-2655-5. PubMed DOI

YANG Y, GAO X, TAO X, GAO Q, ZHANG Y, YANG J. Combined effect of FTO and MC4R gene polymorphisms on obesity in children and adolescents in Northwest China: a case-control study. Asia Pacific J Clin Nutr. 2019;28:177–182. PubMed

YOUNG EH, WAREHAM NJ, FAROOQI S, HINNEY A, HEBEBRAND J, SCHERAG A, O’RAHILLY S, BARROSO I, SANDHU MS. The V103I polymorphism of the MC4R gene and obesity: population-based studies and meta-analysis of 29 563 individuals. Int J Obes (Lond) 2007;31:1437–1441. doi: 10.1038/sj.ijo.0803609. PubMed DOI PMC